Back to Search Start Over

A novel mutation in the GARS gene in a Malian family with Charcot-Marie-Tooth disease.

Authors :
Yalcouyé A
Diallo SH
Coulibaly T
Cissé L
Diallo S
Samassékou O
Diarra S
Coulibaly D
Keita M
Guinto CO
Fischbeck K
Landouré G
Source :
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2019 Jul; Vol. 7 (7), pp. e00782. Date of Electronic Publication: 2019 Jun 07.
Publication Year :
2019

Abstract

Background: Charcot-Marie-Tooth (CMT) disease is a very heterogeneous neurological condition with more than 90 reported genetic entities. It is the most common inherited peripheral neuropathy; however, cases are rarely reported in sub-Saharan Africa. In addition, only few families, mostly of Caucasian ancestry, have been reported to have Charcot-Marie-Tooth disease type 2D (CMT2D) mutations. To date no case of CMT2D was reported in Africa. We present here a consanguineous family with CMT phenotype in which a novel mutation in the GARS (glycyl-tRNA synthetase) gene was identified.<br />Methods: Patients were examined thoroughly and nerve conduction studies (NCS) were performed. DNA from the proband was used for CMT gene panel testing (including 50 genes, PMP22 duplication and mtDNA). Putative mutations were verified in all available family members to check for segregation.<br />Results: Two individuals, a male and a female, were found to be affected. Symptoms started in their teenage years with muscle weakness and atrophy in hands. Later, distal involvement of the lower limbs was noticed. Patients complained of minor sensory impairment. NCS showed no response in the upper as well as the lower limbs. Genetic testing surprisingly identified a novel heterozygous missense mutation c.794C>A (p.Ser265Tyr) in the GARS gene associated with CMT2D. This variant segregated with the disease in the family and was also seen in the mother who presented no symptoms.<br />Conclusion: This is the first report of a genetically confirmed CMT2D case in Africa, expanding its genetic epidemiology. Increasing access to genetic testing may reveal more novel CMT variants or genes in the African population that could be relevant to other populations and further our understanding of their mechanism.<br /> (© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.)

Details

Language :
English
ISSN :
2324-9269
Volume :
7
Issue :
7
Database :
MEDLINE
Journal :
Molecular genetics & genomic medicine
Publication Type :
Academic Journal
Accession number :
31173493
Full Text :
https://doi.org/10.1002/mgg3.782